References
- Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol. 2003;14:469–477
- Olsen S, Mogensen CE. How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature. Diabetologia. 1996;39:1638–1645
- Hovind P, Rossing P, Tarnow L, et al. Progression of diabetic nephropathy. Kidney Int. 2001;59:702–709
- Chow FY, Nikolic-Paterson DJ, Ma FY, et al. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia. 2007;50:471–480
- Furuta T, Saito T, Ootaka T, et al. The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis. 1993;21:480–485
- Joo KW, Hwang YH, Kim JH, et al. MCP-1 and RANTES polymorphisms in Korean diabetic end-stage renal disease. J Korean Med Sci. 2007;22:611–615
- Maeda S. Do inflammatory cytokine genes confer susceptibility to diabetic nephropathy? Kidney Int. 2008;74:413–415
- Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun. 1999;259:344–348
- Karadeniz M, Erdogan M, Cetinkalp S, et al. Monocyte chemoattractant protein-1 (MCP-1) 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy. Endocrine. 2010;37:513–517
- Cheng J, Liu RH. Study on the correlation of the A2518G polymorphism of MCP-1 gene and diabetic nephropathy in type 2 diabetic subjects. Chin J Diabetes. 2007;15:87–88 (in Chinese)
- Moon JY, Jeong L, Lee S, et al. Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus. Korean Med Sci. 2007;22:810–814
- Tang HW, HU DL, LIU TJ, et al. A study on the association of MCP-1 gene polymorphism with type 2 diabetes and diabetic nephropathy in Zhuang minority population. Chin J Diabetes. 2009;17:430–436 (in Chinese)
- Wang Y, Chen JN, Jiang PP, et al. A correlation research between the monocyte chemoattractant protein-1 gene -2518G/A polymorphism and diabetic nephropathy. Chongqing Medicine. 2013;42:363–366 (in Chinese)
- Ahluwalia TS, Khullar M, Ahuja M, et al. Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians. PLoS One. 2009;4:1–10
- Cheng J, Mo ZY, Feng YM, et al. Study on the correlation of the A2518G polymorphism of MCP-1 gene and diabetic nephropathy in type 2 diabetic subjects. China Clin Prac Med. 2010;4:74–75 (in Chinese)
- Wang SN, LaPage J, Hirschhberg R. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int. 2000;57:1002–1014
- Cheng J, Diaz Encarnacion MM, Warner GM, et al. TGF-beta 1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process. Am J Physiol Cell Physiol. 2005;289:C959–C970
- Tesch GH. MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol. 2008;294:697–701
- Chow FY, Nikolic-Paterson DJ, Ozols E, et al. Monocyte chemoattractant protein-1 promotes diabetic renal injury in streptozotocin-treated mice. Kidney Int. 2006;69:73–80
- Rivero A, Mora C, Muros M, et al. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci (Lond). 2009;116:479–492
- Kanamori H, Matsubara T, Mima A, et al. Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochem Biophys Res Commun. 2007;360:772–777
- Fenoglio C, Galimberti D, Lovati C, et al. MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging. 2004;25:1169–1173
- Mori H, Kaneko Y, Narita I, et al. Monocyte chemoattractant protein-1 A-2518G gene polymorphism and renal survival of Japanese patients with immunoglobulin A nephropathy. Clin Exp Nephrol. 2005;9:297–303
- Malafronte P, Vieira JM Jr, Pereira AC, et al. Association of the MCP-1 -2518 A/G polymorphism and no association of its receptor CCR2 -64 V/I polymorphism with lupus nephritis. J Rheumatol. 2010;37:776–782
- Piotrowski P, Lianeri M, Gasik R, et al. Monocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism might be associated with renal disease and thrombocytopenia of SLE. Biomed Biotechnol. 2010;130265:1--6
- Kim HL, Lee DS, Yang SH, et al. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal diseases of SLE. Am J Kidney Dis. 2002;40:1146–1152